Our Jang Tae-hyun is on the line to tell us what decision they made.
Tae-hyun? Just half an hour ago, an independent panel, the Central Pharmaceutical Affairs Advisory Committee, announced that they are putting off the decision on whether AstraZeneca can be administered to elderly people those over the age of 65.
They said that it can be given to those over the age of 18, but for those over 65, more data is needed.
It s the second panel in the country to evaluate this vaccine.
For a fair evaluation of its safety and efficacy, South Korea s Ministry of Food and Drug Safety is getting reviews from three different expert groups.